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1. Introduction 
Toxoplasma gondii (T. gondii) is a ubiquitous, coccidian intracellular protozoan parasite that 
causes toxoplasmosis, a cosmopolitan zoonosis. Toxoplasma infections are reported in 
approximately one-third of the world’s population but most are asymptomatic. The 
infections are mainly acquired through consumption of raw or uncooked meat containing 
viable tissue cysts or by contamination with highly resistant oocysts in foods, soil and water. 
In the symptomatic condition, toxoplasmosis occurs congenitally through transplacental 
transmission from a primarily infected mother during pregnancy that leads to intrauterine 
death, spontaneous abortion or severe congenital defects such as retinochoroiditis, 
hydrocephalus or mental retardation (Wong & Remington, 1994; Tenter et al, 2000; 
Sukthana, 2006). Toxoplasmosis is also a serious and life-threatening disease found in 
immunocompromised patients such as in organ transplant recipients (Aubert et al, 1996), 
patients with cancer (Herold et al, 2009) or AIDS (Nissapatorn et al, 2004).  
The laboratory diagnosis of toxoplasmosis can be done in many ways including serology, 
the isolation of T. gondii after inoculation into experimental animals, histological 
examination, and molecular analysis (Fleck & Kwantes, 1980; Meganathan et al, 2010). Of 
these, serological tests to determine specific antibodies such as IgG, IgM, IgE or IgA are 
currently the first-line methods of diagnosis to differentiate recent or chronic infections with 
T. gondii (Sensini, 2006). Diagnosis of symptomatic toxoplasmosis is not straight forward 
due primarily to the clinical manifestations being varied and it can mimic other diseases 
(Santoni & Santoni-Willians, 1993; Hurt & Tammaro, 2007). Traditionally, the diagnosis of 
recently acquired toxoplasmosis has been detected either by demonstrating a specific 
immunoglobulin (Ig) M antibodies, a significant increase in specific IgG antibodies, or both. 
Due to the high IgG antibodies titres to T. gondii infections among the majority of 
immunocompetents (Remington & Desmonts, 1990) and the persistence of specific IgM 
antibodies in some individuals this has led to complications in the interpretation of 
serodiagnostic results even when toxoplasmosis was clinically suspected (Brooks et al, 1987; 
Bobic et al, 1991; Bertozzi et al, 1999). Moreover, a primary acquired Toxoplasma infection 
during pregnancy and the risk of congenital toxoplasmosis is a medical (clinical and 
diagnostic) challenge for the clinicians dealing with this tropical and infectious parasitic 
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disease. Therefore, a sensitive and specific method is mandatory for the management of 
patients with a high probability of being infected by T. gondii (Kotresha & Noordin, 2010). In 
recent years, a number of new methods including new serodiagnostic tools have been 
developed towards improving the ability to diagnose recently acquired Toxoplasma 
infections during pregnancy in order to limit congenital infections (CI) in the fetus and 
newborn (Remington et al, 2004). From this point of view, this chapter is aiming to highlight 
the significant contributions of recently developed serological methods such as the IgG 
avidity test and serodiagnosis using various recombinant proteins and its implications for 
the management, including diagnosis and treatment, of toxoplasmosis, particularly in 
pregnant women or HIV-infected patients among the so called “high risk” population.  
2. Recombinant proteins in serodiagnosis of toxoplasmosis 
Currently, antigens used for commercial serological assays for the detection of specific anti-
Toxoplasma antibodies are mainly based on whole tachyzoite lysates. However, the major 
disadvantage of this kind of antigen is its inconsistant quality due to contamination by 
extraparasitic components during the processing of preparations that result in interassay 
variability (Aubert et al, 2000). The use of recombinant antigens cloned in suitable 
expression vectors has been proven to improve consistency of the tests and to reduce the 
costs of production (Hiszczyjska-Sawicka et al, 2003). However, because of its complex life 
cycle, a number of proteins produced at different stages of the parasite life cycle can play 
different roles in stimulating host immune responses during the infectious process. 
Furthermore, a precise distinction between acute and latent invasion may be difficult since 
IgM antibodies, a specific marker for early infection, could be present in sera for many years 
(Meek et al, 2001). Therefore, certain antigens that are specific to the acute or chronic stages 
of the infection that produce specific IgG antibodies could serve as a mean to distinguish the 
recent from a chronic infection. 
Tachyzoites, the rapidly multiplying stage of the parasite, is considered to be responsible for 
active toxoplasmosis. In contrast, bradyzoites, a dormant stage that persists within cysts and 
is thought to evade the immune response by their absence of expression of 
immunodominant antigens throughout a prolonged infection (Smith et al, 1996). Several 
studies have shown that the main targets for antibody production during the acute and 
chronic phase of Toxoplasma infection are the surface antigens (SAG) present in the 
tachyzoite membrane (Mineo et al, 1980) and their usefulness as antigens has been shown. 
Secretory proteins: micronemes (MIC), rhoptries (ROP) and dense granules (GRA) released 
from three distinct tachyzoite parasite organelles during invasion are other potential 
diagnostic antigens of interest as markers of acute infection. ROP and MIC released during 
the cell invasion, and GRA that is discharged from parasitophorous vacuoles after invasion, 
and continues during the intracellular residence of the organism (Carruthers & Sibley, 1997). 
The usefulness of several recombinant antigens of T. gondii that have been produced and 
extensively evaluated for their potential use as diagnostic antigens in ELISA to detect 
specific IgG antibodies during the early phase of infection, allows for differentiation of an 
acute from a chronic infection. Furthermore, if only a single serum sample is available, an 
IgG avidity test using recombinant antigens is seen to be more appropriate for detecting a 
recently acquired infection. The sensitivity and specificity for these antigens have been 
reported to be in the range of 80% to 100%. These antigens have included: 
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2.1 Rhoptries antigens (ROP) 
Rhoptries are unique secretory organelles shared by all Apicomplexan invasive stages. More 
than 30 ROPs of T. gondii have been identified (Bradley et al, 2005). They are exocytosed 
upon host cell invasion and their contents are involved in many functions fundamental for 
the parasite to enter into host cells, and for the establishment and maintenance of the 
parasitophorous vacuole membrane and acquisition of nutrients (Dubremetz, 2007). The use 
of recombinant ROP antigens (rROP) has been largely described as the antigenic substrate to 
use in ELISA tests to detect infection with T. gondii (vanGelder et al, 1993; Aubert et al, 2000; 
Chang et al, 2011). rROP1 has shown its diagnostic value in IgG ELISA avidity tets for 
identification of acute infections (Holec-Gąsior et al, 2009, 2010a). There is data regarding 
the potential use of rROP2 for the diagnosis of acute toxoplasmosis that have focused on IgG 
reactivities (Martin et al, 1998; Chang et al, 2011). In a mouse model, IgM antibody against 
rROP4 was significantly higher than IgG antibodies with a peak of detection coming on the 
turn of the acute to a latent infection (Gatkowska et al, 2010).  
2.2 Microneme proteins (MIC) 
MICs are proteins involved in recognition and/or binding to the host cell (Soldati et al, 
2001). At least 12 MICs have been identified from T. gondii (Carruthers & Tomley, 2008). 
However, little is known whether rMIC can be used as an antigen. rMIC1 has thus far been 
the only protein shown to be highly reactive against sera of patients with acute 
toxoplasmosis (Holec et al, 2008). 
2.3 Dense granule antigens (GRA) 
Among identified GRA antigens, at least 12 out of 14 GRA antigens have been detected from 
T. gondii tachyzoites as excretory/secretory antigens (Nam, 2009). They are believed to be 
involved in parasite survival and virulence (Michelin et al, 2009; Rome et al, 2008). GRA1 is 
the major secretory antigen recognized in humans chronically infected with Toxoplasma. 
GRA2 has been shown to induce strong antibody and T-cell responses in both humans and 
experimental mice (Sharma et al, 1984; Brinkmann et al, 1993; Murray et al, 1993; Prigione et 
al, 2000). While, GRA6 and GRA7 are also shown strong antibody responses in the acute 
phase of Toxoplasma infection (Gatkowska et al, 2006). GRA7 was found in the 
parasitophorous vacuole and cytoplasm of the host cell infected with the tachyzoite stage 
(Jacobs et al, 1998). As a consequence, GRA7 is only released after the rupture of infected 
cells in the acute stage of infection and it is only then that it is exposed to the hosts’ immune 
system. Therefore, detection of GRA7 antibodies would be expected to be a good candidate 
to use for serodiagnosis. Several rGRA antigens such as rGRA2 (Golkar et al, 2007; Holec-
Gąsior et al, 2009), rGRA6 (Aubert et al, 2000; Golkar et al, 2008), rGRA7 (Aubert et al, 2000; 
Pietkiewicz et al, 2004; Pfrepper et al, 2005; Pietkiewicz et al, 2007), and rGRA8 (Pfrepper et 
al, 2005; Gatkowska et al, 2006; Babaie et al, 2009) have been proposed as markers to indicate 
acute infections. rGRA4 and rGRA7, but not rROP2, have been shown to be valuable in 
differentiating acute and chronically infected individuals for both adult and congenital 
toxoplasmosis (Nigro et al, 2003; Altcheh et al, 2006). In contrast, rGRA1 was reported to be 
a marker for chronic infections (Ferrandiz et al, 2004; Pietkiewicz et al, 2004). 
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2.4 Surface antigens (SAG) 
Five major SAG antigens specific to the tachyzoite stage have been identified (Couvreur et 
al, 1988). Of these, the SAG1, SAG2, and SAG3 antigens are the main proteins expressed on 
the surface of tachyzoites. They are involved in the process of host cell invasion after 
infection (Mineo & Kasper, 1994; Grimwood & Smith, 1996), and are highly immunogenic 
for IgG responses. SAG1 and SAG3 are stage-specific antigens of the tachyzoites and are 
highly conserved in most isolates (Gross et al, 1996; Wu et al, 2009). In contrast, SAG2 has 
been identified from both bradyzoites and tachyzoites (Lekutis et al, 2000). SAG4 is another 
surface protein that is specifically expressed by bradyzoites (Knoll & Boothroyd, 1998). 
rSAG1 successfully detected IgG antibodies in the acute phase of infection (Pietkiewicz et al, 
2004), but the highest response to rSAG1 was found during latent infections (Gatkowska et 
al, 2010). Some studies did show that rSAG2 was effective in specifically detecting IgG 
antibody to T. gondii in patients with acute toxoplasmosis (Parmley et al, 1992). However, 
more recent studies showed that rSAG2 was produced in acute and chronic infections (Lau 
& Fong, 2008), whereas rSAG2A was present only during the acute phase of toxoplasmosis 
(Béla et al, 2008). 
2.5 Combinations of recombinant antigens 
A cocktail of recombinant antigens help to improve the serological diagnosis of clinical 
toxoplasmosis. A combination of rGRA1 and rGRA6 has shown promising results when 
being preliminary tested (Lecordier, 2000). While, the triple combination of SAG1, ROP1 and 
GRA7 have also been successfully tested in a preliminary format (Aubert, 2000). Different 
combinations of recombinant antigens that have been evaluated and successfully increase 
the sensitivity of serodiagnosis from chronic toxoplasmosis are summarized in Table 1.  
 
References Combinations of recombinant antigens 
Aubert et al, 2000 rSAG1, rROP1, and rGRA7 
rGRA7, rGRA8, and rSAG1 
Li et al, 2000 rGRA7, rGRA8, rSAG2, and rH4 
Nigro et al, 2003 rROP2 and rGRA7 
Pietkiewicz et al, 2004 rSAG1, rGRA1, and rGRA7 
Holec et al, 2008 rGRA1, rGRA7, and rSAG1 
rGRA8, rSAG2, and rGRA6 
rMic1ex2, rMAG1, and rMIC3 
Cóceres et al, 2010 rHSP20, rSAG1, and rGRA7 
rHSP20 and rSAG1 
rHSP20 and rGRA7 
rSAG1 and rGRA7 
Holec-Gąsior & Kur, 2010 rMAG1, rSAG1, and rGRA5 
rGRA2, rSAG1, and rGRA5 
rROP1, rSAG1, and rGRA5 
Holec-Gąsior et al, 2010b rMAG1 + rSAG1 + rGRA7 
Table 1. Selected combination of recombinant antigens that increase the sensitivity of 
serodiagnosis of chronic toxoplasmosis. 
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Furthermore, the multiple combinations of recombinant antigens P22, P25, P29, and P35 has 
confirmed that a cocktail of antigens might be helpful to differentiate between acute and 
chronic infections when tested against specific IgG antibodies in human samples (Li, 2000). 
Based on these results, it clearly shows that the combination of recombinant antigens is 
mandatory in the attempt to distinguish between acute and chronic Toxoplasma infections. 
Nonetheless, the combination of GRA1 and GRA6 for distinguishing between acute and 
chronic infections was unsuccessful found in pregnant women (Ferrandiz et al., 2004). The 
combinations of recombinant antigens that could be used to distinguish between acute and 
chronic infections are summarized in Table 2. 
 
References Combinations of recombinant antigens 
Li et al, 2000  rGRA8, rSAG2, rGRA2, and rGRA7  
Beghetto et al, 2003  rGRA3, rGRA7, rMIC3, and rSAG1  
Pietkiewicz et al, 2007  rGRA1, rGRA7 and rSAG1  
Table 2. Selected combination of recombinant antigens that use to distinguish between acute 
and chronic infections. 
3. IgG-avidity: A real-time serodiagnosis forToxoplasma infection 
It seems that a conventional single serum assay does not provide an accurate diagnosis in 
differentiating between a recently acquired primary infection and a chronic infection 
(Lappalainen & Hedman, 2004). The IgG-avidity test is an assay that measures the antigen-
binding avidity/affinity of IgG antibodies against T. gondii infection and was first 
introduced to try to eliminate this problem (Hedman et al, 1989). This avidity test has 
significantly lessened the possibility of misdiagnosis, by assisting in determining a 
difference between a recently acquired (primary/acute) and a chronic (latent/past/remote) 
infection. This has greatly decreased the requirement for a confirmatory (a single or the first 
sample) or follow-up serological tests, to remove any doubts or anxiety for further testings 
(Cozon et al, 1998; Liesenfeld et al, 2001; Montoya et al, 2002; Remington et al, 2004; Press et al, 
2005; Reis et al, 2006; Candolfi et al, 2007; Nissapatorn et al, 2011). Hence, the measurement of 
IgG-avidity has proved to be a highly sensitive method, used to assess the early time of 
antigenic challenge and it is especially recommended for use in combination with other 
existing conventional serological assays (Lappalainen & Hedman, 2004; Nissapatorn et al, 
2011). The IgG avidity test has so far been the best serological approach that can offer a rapid 
diagnosis of a recently acquired Toxoplasma infection in a single serum sample. Until now the 
IgG-avidity test has been tested and used in several different clinical scenarios: a recently 
acquired Toxoplasma infection, primary acquired infection during pregnancy, congenital 
toxoplasmosis, ocular toxoplasmosis (OT), and in immunocompromised individuals such as 
cancer patients, solid organ transplant recipients or persons living with HIV/AIDS.  
3.1 Acute (recently) acquired Toxoplasma infection 
Approximately, one-third of the world’s populations are infected with T. gondii. However, 
the majority of these are either mild with non-specific clinical symptoms or asymptomatic. 
Lymphadenopathy is significantly present in only 3-7% of clinical cases but is the most 
common form in immunocompetent individuals (Gard & Magnusson, 1951; McCabe et al, 
1987). The clinical features show localized, nontender and nonsuppurative lymphadenopathy 
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as a result of Toxoplasma infection. Of note, lymphadenopathy may persist for months and 
may mimic clinically or histologically with neoplastic diseases such as lymphoma or 
carcinoma of the head, neck and breast (Lappalainen & Hedman, 2004). The diagnosis of 
toxoplasmic lymphadenopathy is based on serology and lymphnode biopsy.  
Serological techniques have traditionally been used but shown some limitations in 
evaluating the timing of Toxoplasma infections. The IgG avidity test has since been 
introduced for differentiation between recently acquired and past infections in the course of 
toxoplasmic lymphadenopathy. The duration of low avidity values in patients with 
lymphadenopathy is not well defined. Lecolier and Pucheu observed patients whose sera 
had a low IgG avidity for as long as 20 weeks after the acquisition of infection (Lecolier & 
Pucheu, 1993). A low IgG avidity occurs during < 3 months of lymphadenopathy (Holliman 
et al, 1994). In the present study, low IgG avidity values were still observed 5 months after 
the first serological examination in 6 of 19 patients (31.6%) with lymphadenopathy (Paul, 
1999). Whereas, a high IgG avidity test resulted from an individual who had a recent onset 
of lymphadenopathy of at least 4 months (Montoya et al, 2004). Therefore, a high IgG 
avidity value strongly excludes a recent infection, that is, one that was acquired during the 
previous 5 months, but a low avidity is not a safe marker for an early stage of infection 
(Paul, 1999).  
3.2 Primary acquired Toxoplasma infection during pregnancy 
Based on epidemiological data, the prevalent rate of Toxoplasma infection in pregnant 
women is generally high in many geographical locations and plausible risk factors play an 
important role in Toxoplasma acquisition found among these women. However, the rate of 
acute (recent) acquired Toxoplasma infection is unexpectedly low in pregnant women. The 
gestational stages of pregnancy are determined by the impacts of vertical transmission from 
the infected mother to the fetus; primary Toxoplasma infection in early trimester of 
pregnancy may result in severe clinical disease, in contrast, congenital toxoplasmosis as a 
result of maternal infection during third trimester of pregnancy is usually subclinical at 
birth (Desmonts, 1979). The clinical symptoms of acute toxoplasmosis during pregnancy are 
usually subclinical or associated with non-specific symptoms. Therefore, the diagnosis is 
mainly based on serological responses of pregnant women. Serological results are however 
difficult to interpret and that has contributed to the most challenging situation during 
pregnancy 
In clinical practice, simultaneous testing for specific IgG and IgM antibodies against T. gondii 
in serial serum samples collected at an interval of 3 weeks is the early step in routine 
screening for Toxoplasma infection. Of note, the presence of specific IgG and/or IgM 
antibodies against T. gondii in a single serum sample drawn during pregnancy cannot be 
used to determine if the infection was chronic or recently acquired. Therefore, successive 
tests and the definitive diagnosis are required as a result of this initial screening. Factors 
such as the trimester of infection and maternal-neonatal therapeutic treatments are the main 
contributing factors to the variation of immunological responses of both mother and neonate 
(Sensini, 2006). Early and accurate diagnosis is crucial during pregnancy, as the women then 
require immediate therapeutic options. In addition, IgG and IgM antibodies against T. gondii 
are the first-line serological diagnosis for the detection of recent or chronic infections. A 
seropositive woman for only IgG antibodies, is unlikely to have recently acquired 
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toxoplasmosis due to the level of specific Toxoplasma-IgG antibodies which is an unreliable 
indicator for acute infection (Robert et al, 2001). Following an acute Toxoplasma infection in 
the mother, the evidence for a rapidly transmitted infection to the fetus has been observed. 
Hence, early diagnosis of an acute infection during pregnancy is crucial to determine 
whether treatment of the infected mother can prevent vertical transmission to the fetus.  
The measurement of IgG avidity has been developed to avoid using confirmatory tests from 
a second serum sample for the possibility of a recently acquired infection obtained from the 
initial serodiagnostic test. A specific positive IgG test with a low avidity has been used to 
confirm a recent primary acquired Toxoplasma infection by using a single serum indicator 
(Joynson et al, 1990; Lappalainen et al, 1993; Holliman et al, 1994; Jenum et al, 1997; 
Liesenfeld et al, 2001; Roberts et al, 2001; Abdel Hameed & Helmy, 2004; Press et al, 2005; 
Reis et al, 2006; Nissapatorn et al, 2011). Due to it being a safe and useful tool for screening 
for high sensitivity, an IgG-avidity test is able to verify that the majority of pregnant women 
who presented with Toxoplasma IgM antibodies did not have a recently acquired infection 
(Lappalainen et al, 1993; Nissapatorn et al, 2011). IgG-avidity is therefore recommended to 
serve as the primary tool for an IgG assay and a sensitive IgM test (Lappalainen & Hedman, 
2004; Olariu et al, 2006). Moreover, the IgG-avidity test can be used as a subsequent 
measurement to confirm the IgM diagnosis, as shown in suspected cases of acute recent 
toxoplasmosis in immunocompetent patients (Table 3).  
 
Clinical scenarios Diagnostic tests 
Immunocompetents   
Acute infection 
(primary acquired infection) 
Toxoplasma-IgG and Toxoplasma-IgM antibodies, 
followed by the measurement of IgG-avidity test (if 
Toxoplasma-IgM positive) 
Immunity  
(latent/chronic/past infection) 
Toxoplasma-IgG antibodies  
Ocular toxoplasmosis  
(acute retinochoroiditis) 
Toxoplasma-IgG and Toxoplasma-IgM antibodies for the 
detection of past exposure; seldom useful to show 
acute infection.  
Congenital toxoplasmosis  
(maternal-fetal infection) 
Serology for Toxoplasma-IgG, -IgM and -IgA antibodies 
of the newborn and the mother. Toxoplasma-PCR (and 
culture, if available) from clinical specimens such as 
blood, urine and cerebrospinal fluid (CSF).  
Immunosuppressed patients 
(cancer patients, organs 
transplant or HIV-infected 
patients)  
Toxoplasma-IgG and Toxoplasma-IgM antibodies for the 
detection of past exposure; a second sample is needed 
to show reactivation. Toxoplasma-PCR (and culture, if 
available) to detect ongoing active infection using 
blood and CSF specimens.  
Table 3. Laboratory diagnosis in different clinical scenarios of toxoplasmosis.  
When a primary acquired infection in a pregnant mother is diagnosed either by 
seroconversion for IgG or being seropositive for IgM antibodies followed by a low IgG-
avidity, the infected mother should be referred immediately for medical assessment to an 
obstetrician who should include further tests including molecular analysis using an 
amniotic fluid sample to determine any fetal infection (Hohlfeld et al, 1994; Jenum et al,  
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References Sero-pattern Interpretation Comments 
Montoya & 
Liesenfeld, 2004  
National committee 
for clinical laboratory 
standard, 2004  
Remington et al, 2004 
Nissapatorn et al, 
2011  
IgG+IgM+ 
Mother  
(a) Past or 
recently 
acquired 
infection  
 Risk for congenital infection 
(CI) 
 Take gestation period into 
account. Serological tests for 
specific Toxoplasma-IgA and -
IgE antibodies and IgG-avidity  
(b) False-
positive 
 No risk for CI  
 Serological tests for specific 
Toxoplasma-IgA and -IgE 
antibodies and IgG-avidity 
Sharma et al, 1983  
Partanen et al, 1984  
Villena et al, 1999 
Gross et al, 2000 
Pinon et al, 2001 
Remington et al, 2001 
Montoya, 2002 
Flori et al, 2004 
Nielsen et al, 2005  
IgG+IgM+  
Newborn 
(a) Maternal 
antibies 
 No risk for CI 
 Collect 2nd serum sample 10 
days after birth to confirm 
contaminating maternal specific 
Toxoplasma-IgM antibodies. Test 
in parallel maternal and 
neonatal specific Toxoplasma-IgG 
antibodies by Western blotting 
(WB) or ELISA. Serological 
follow-up for 1 year to confirm 
seronegativity for specific 
Toxoplasma-IgG antibodies. 
 Check for stable IgG-avidity 
index. 
(b) Maternal 
and neonatal 
antibodies 
 CI after maternal infection in 
the third trimester (IgA+) or in 
the last month (IgA-) of 
pregnancy 
 Collect 2nd serum sample 10 
days after birth in parallel 
maternal and neonatal specific 
IgG antibodies by WB or 
ELISA. Serological follow-up 
for 1 year to demonstrate the 
persistence of specific 
Toxoplasma-IgG antibodies.  
 Check for increased IgG- 
avidity index 
Table 4. The measurement of IgG avidity test for toxoplasmosis in pregnant woman and 
newborn.  
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1998). The combination of a sensitive test for Toxoplasma-specific IgM antibodies and the 
measurement of IgG avidity had shown the highest predictive value in association with the 
possible time of infection (Petersen et al, 2005; Press et al, 2005). When a high IgG-avidity 
result was found in women within their first trimester of pregnancies, it provided a strong 
indicator against primary infection. As there is a low risk of congenital toxoplasmosis there 
is no intervention necessarily required. In general, IgG-avidity has been used to confirm 
past or recently acquired infection or false-positive results in pregnant women who showed 
seropositive for IgG and IgM antibodies (Table 4) and this has been recommended by 
several authors (Montoya & Liesenfeld, 2004; National committee for clinical laboratory 
standard, 2004; Remington et al, 2004). 
3.3 Congenital toxoplasmosis  
Toxoplasmosis has historically been recognized as one of the most important pathogens 
causing congenital infection (CI) and it has also been comprised in “TORCHs” infections. 
Transplacental (vertical, congenital, materno-fetal) transmission of T. gobdii can be a serious 
complication as a result of primary acquired infection during pregnancy. Of note, most 
infected children are asymptomatic at birth but they can manifest problems during later 
decades of life associated with ocular (acute retinochoroiditis) and neurological 
involvements (hydrocephalus).  
Postnatal diagnosis is a complex process due to the presence of passive maternal IgG 
antibodies or the variability of perinatal IgM antibody findings (Desmonts et al, 1985; Daffos 
et al, 1988). Moreover, the level of specific IgA and IgM antibodies may not be able to be 
detected in all children with CI. Hence, a combination of specific IgA and IgM antibodies is 
the recommended approach for serological measurements in affected children (Naessens et 
al, 1999). In addition, determination of IgG-avidity and/or serological detection of specific 
IgG could serve as an alternative option for the diagnosis of congenital toxoplasmosis (Said 
et al, 2011). Combined with serological tests, the role of PCR in detecting T. gondii organism 
in amniotic fluid sample has been found to be more promising in terms of sensitivity and 
specificity during antenatal testing compared to postnatal diagnosis (Hohlfeld et al, 1994; 
Jenum et al, 1998; Yamada et al, 2011). 
IgG avidity is generally not tested in the neonate due primarily to its having a similar 
pattern to the infected mother. However, a previous study has demonstrated that a 
significant maturation of IgG avidity was shown in congenitally infected children during 
postnatal follow-up (Lappalainen et al, 1995). In contrast, long-term therapy with 
pyrimethamine-sulphonamide, as opposed to treatment with spiramycin alone, was found 
to slow the progression of the avidity index (Flori et al, 2004). An IgG-avidity result in the 
first month of the postnatal period usually represents a combination of both mother and the 
newborn’s own IgG antibodies and that depends on several contributing factors such as the 
sampling time, the IgG-titre and avidity of the mother as well as the newborn (Lappalainen 
& Hedman, 2004). In the absence of maternofetal transmission, the avidity index remains 
stable until the disappearance of passively transmitted specific antibodies from the infected 
mothers (Sensini, 2006). It is of interest that there is a delay of maturation of IgG-avidity in 
congenital toxoplasmosis that can be demonstrated by performing the test on antibodies 
eluted from dried blood spots (Guthrie cards) to detect, at birth, a maternal primary 
infection acquired during the second or third trimester of pregnancy and to evaluate 
retrospectively the risk for high suspicion of CI during late infancy (Buffolano et al, 2004). In 
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general, it has been recommended that IgG-avidity should be used to confirm CI in the 
neonates (Table 4) being seropositive for both IgG and IgM antibodies either from maternal 
antibodies or both maternal and neonatal antibodies (Sharma et al, 1983; Weiss et al, 1988; 
Chumpitazi et al, 1995; Flori et al, 2004; Nielsen et al, 2005). 
3.4 Ocular toxoplasmosis  
Ocular toxoplasmosis (OT) occurs mainly in the uveal tract and it is the most common cause 
of posterior uveitis in immunocompetent persons. Retinochoroiditris is the most common 
lesion found among non-specific clinical manifestations of OT. In most cases, OT is the 
result of reactivated or congenital rather than from acquired Toxoplasma infections (Perkins, 
1973; Ronday et al, 1995; Montoya & Remington, 1996). Clinical diagnosis of OT is based on 
the manifestations of characteristic biomicroscopic features (Rothova et al, 1986; de Jong, 
1989; Tabbara, 1994).  
Over more than three decades, many different serological tests have been introduced to 
detect specific IgG antibodies against T. gondii that can indicate chronic infections (Holliman 
et al, 1991). The detection of specific IgM antibodies indicates a recently acquired infection, 
however, it is found to have a high rate of false-positive results due to persisting IgM 
antibodies (Leisenfeld et al, 1997). Moreover, the absence or low levels of specific IgM 
antibodies in reactivated OT, cannot therefore serve as a reliable serological marker for this 
disease (Lappin et al, 1995; Ronday et al, 1995; Garweg et al, 1998; Klaren et al, 1998). 
Serological diagnosis of OT is insensitive (Rothova et al, 1986; Kijlstra et al, 1989; Holliman 
et al, 1991) and is of limited value (Lappalainen & Hedman, 2004). Also, the role of an IgG 
avidity measurement is to confirm the stage of chronic infection and to raise the suspicion of 
an ongoing reactivated OT (Paul, 1999; Garweg et al, 2000). 
3.5 Cerebral toxoplasmosis 
In contrast to the majority of immunocompetents persons, toxoplasmosis can cause serious 
clinical outcomes in immunocompromised individuals such as patients with AIDS or organ 
transplant recipients. In patients with an advanced HIV infection, toxoplasmosis is one of 
the most common central nervous system diseases associated with opportunistic infections 
that cause high rates of morbidity and mortality. Cerebral toxoplasmosis (CT) is the most 
common clinical disease entity and it causes focal intracerebral lesion(s) in patients with 
AIDS. Among AIDS patients, >95% of CT is due to the reactivation of latent (chronic) 
Toxoplasma infections as a result of the progressive loss of cellular immunity (Luft & 
Remington, 1988). In clinical practice, the incidence of CT patients is related both to 
Toxoplasma IgG seropositivity and to the CD4 cell count. The risk of developing CT among 
seropositive patients with AIDS was 27 times that of seronegative ones (Oksenhendler et al, 
1994). The clinical presentations of CT depend on the number of lesions and locations. 
Headache, hemiparesis and seizure (Porter & Sande, 1992; Nissapatorn et al, 2004; Vidal et 
al, 2005) are among the most common neurological presentations found in CT patients. 
Other clinical manifestations include disarthria, movement disorders, memory and 
cognitive impairments and neuropsychiatric abnormalities. These neurological deficits 
remain in surviving patients even after a good clinical response to therapy (Hoffmann et al, 
2007). More than 50% of CT patients may have focal neurological findings. The empirical 
diagnosis is based on a low CD4 count of less than 200 cells/cumm, computer tomography 
scans will show ring enhancing lesions, seroevidence of specific IgG, IgM or both antibodies 
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to T. gondii, and a good response to anti-Toxoplasma therapy. Specific anti-Toxoplasma 
therapy is initiated in a highly suspicious or confirmed toxoplasmosis. CT is a life-
threatening but treatable condition provided there is early diagnosis and treatment.  
In HIV-infected patients, serological titres are often low and that makes for disease phase 
definition and therapeutic decisions difficult (Spausta et al, 2003). The determination of IgG 
avidity is another serological marker and it has been shown to be of some help in 
serodiagnosis of Toxoplasma infection among immunocompromised individuals. So far, very 
few studies have used the IgG avidity test for the differentiation of primary and reactivated 
chronic infections in HIV-infected patients. However, there was no significant difference 
between the avidity values in HIV-infected patients with CT and those without clinical signs 
of reactivation (Holliman et al, 1994; Spausta et al, 2003; Adurthi et al, 2010). A liver 
transplant recipient with reactivated toxoplasmosis was first reported by performing an IgG 
avidity test (Lappalainen et al, 1998). This patient was seropositive for T. gondii with high 
avidity indicating a chronic infection before the first transplantation. Subsequencely, 
serological diagnosis showed a rise in specific IgG antibodies, negative for IgM antibodies 
and with a constantly high IgG avidity, indicating a reactivation before the second 
transplantation. Serodiagnosis for T. gondii was negative for both donors. The presence of T. 
gondii DNA was shown by PCR in blood samples and liver biopsy prior to the death of this 
patient. Based on the results obtained, an avidity test for the serological status of T. gondii is 
therefore recommended if there are non-specific clinical symptoms of toxoplasmosis and it 
could be used for the diagnosis in differentiating recently acquired, chronic or secondary 
reactivation of latent toxoplasmosis in immunocompromised patients.  
4. Conclusion 
Estimation of the IgG avidity index is a classical serological method. Antibodies with low 
avidity are detectable at a very early stage of infection whereas high avidity antibodies 
indicate past infections. The measurement of IgG avidity has demonstrated its superior 
diagnostic values in serological interpretations of Toxoplasma infections in different clinical 
scenarios, particularly when timing between chronic and recently acquired infections or 
primary and secondary (reactivated) infections are required. The IgG avidity test represents 
an important addition to other first-line serological methods such as IgG, IgM and IgA 
specific antibodies against T. gondii. Above all, serological diagnosis should be performed in 
combination with culture based and molecular techniques to obtain the best and most 
accurate results.  
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